09:41 AM EST - Neptune Technologies & Bioressources Inc. : reported that its first quarter net loss was $1.41 million or $0.04 per share, compared to a net loss of $1.28 million or $0.03 per share in the year-ago quarter. Total revenue for the quarter decreased 8% to $2.88 million, from $3.13 million in the same quarter of last year. Neptune continues to report positive EBITDA for Neptune Nutraceutical, excluding Acasti Pharma and NeuroBioPharm, of $36,000 for the three-month period ended May 31, 2009, even though the expansion process affected, in the interim, the financial results during the fiscal quarter. Neptune Technologies & Bioressources Inc.
shares V.NTB are trading even at $2.05.
